HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

HCAT

Health Catalyst, Inc.

Healthcare — Health Information Services

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, accountable care organizations, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Buy 2.4 / 5 5 analysts
$1.70
$-0.03 (-1.73%)
Target: $1.90 (11.8%)

Price History

52-Week Range
Sign in to add HCAT to a watchlist or set price alerts.

Fundamentals

Market Cap$152.96M
P/E Ratio (TTM)-
Forward P/E22.43
EPS (TTM)$-3.73
Dividend Yield-
Profit Margin-87.70%
Revenue Growth-10.90%
ROE-103.02%
Debt/Equity123.48
Recommendation Buy 2.4
Analyst Target$1.90
Analysts5
Next Earnings Aug 6, 2026 AMC
Indexes -

Technical Indicators

RSI (14)79.0
Beta1.57
SMA 20-
SMA 40-
52-Week High$4.13
52-Week Low$0.96
50-Day Avg$1.53
200-Day Avg$2.08
Avg Volume$1.52M
Volume$1.80M

Performance Analysis

NEUTRAL

HCAT presents a mixed picture with both positive and negative indicators.

~ Trading at 24% of its 52-week range.
- RSI at 79.0 indicates overbought conditions — a pullback may be due.
- Revenue declined 10.9% year-over-year.
- Operating at a loss with -87.7% margin.
+ Wall Street consensus is "Buy" from 5 analysts.
+ Average analyst target of $1.90 implies 11.8% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:13 UTC

Back to Screener Export Report